Ludwig Maximilian University of Munich

Diseases, Conditions, Syndromes

New marker for better assessing the severity of COVID-19

Biomedical scientists at LMU have found a new marker in the blood of COVID-19 patients. It furnishes insights into the course and development of the disease and could lead to better diagnoses.

Diseases, Conditions, Syndromes

How Roquin controls the activity of immune cells

Ludwig Maximilians University Munich (LMU) immunologists have discovered how mutations in Roquin-1 trigger autoimmunity, but can also improve the body's fight against cancer cells.

Diseases, Conditions, Syndromes

How COVID-19 alters the immune system

COVID-19 reduces the numbers and functional competence of certain types of immune cells in the blood, say LMU researchers. This could affect responses to secondary infections.

Medical research

Defining a healthy microbiome

In a new study, Bärbel Stecher and her team from LMU have shown that, depending on the composition of the microbiome, E. coli bacteria can prevent infections by Salmonella strains.

Medical research

A specific subset of immune cells that mitigates kidney damage

The immune system is highly complex. For example, a particular class of cells called mononuclear phagocytes (MNPs) plays important roles in the uptake and disposal of damaged cells, the elimination of invasive pathogens and ...

page 5 from 24